CLINICAL_TRIALS
research
· 2026-03-23
Clinical Trial Update: Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema [Phase 3]
Summary
A Phase 3 trial is planned to compare AVT29 with Eylea HD in diabetic macular edema and is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alvotech Swiss AG | Conditions: Diabetic Macular Edema | Phase 3 | Status: NOT_YET_RECRUITING